Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

N/ACompletedNCT02422069

Hoffmann-La Roche624 enrolled

Overview

This observational study will provide an opportunity to document local patterns of susceptibility, patient profile, and usefulness of screening in postmenopausal patients coming to gynecology outpatient clinics in Pakistan. This will also capture the initial management of PMO in diagnosed patients. The information gathered will serve as a foundation for developing national guidelines on screening and management of PMO in Pakistan.

Study Type

OBSERVATIONAL

Enrollment

624

Conditions

Postmenopausal Osteoporosis

Eligibility

Sex: FEMALEMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Postmenopausal women * Age 50 years or greater Exclusion Criteria: * Previously diagnosed osteoporosis, or receiving treatment for osteoporosis

Locations (8)

Unnamed facility

Islamabad, Pakistan

Unnamed facility

Karachi, Pakistan

Unnamed facility

Karachi, Pakistan

Unnamed facility

Karachi, Pakistan

Outcomes

Primary Outcomes

Percentage of patients diagnosed with PMO based upon dual-energy X-ray absorptiometry (DXA) results

Time frame: Up to 12 months

Secondary Outcomes

Use of various PMO treatment modalities

Time frame: Up to 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.